Taiwan · Delayed Price · Currency is TWD Grape King Bio Statistics
Total Valuation
Grape King Bio has a market cap or net worth of TWD 18.44 billion. The enterprise value is 16.90 billion.
| Market Cap | 18.44B |
| Enterprise Value | 16.90B |
Important Dates
The next estimated earnings date is Monday, February 23, 2026.
| Earnings Date | Feb 23, 2026 |
| Ex-Dividend Date | Jan 8, 2026 |
Share Statistics
Grape King Bio has 148.14 million shares outstanding. The number of shares has decreased by -0.06% in one year.
| Current Share Class | 148.14M |
| Shares Outstanding | 148.14M |
| Shares Change (YoY) | -0.06% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 12.54% |
| Owned by Institutions (%) | 15.58% |
| Float | 114.62M |
Valuation Ratios
The trailing PE ratio is 15.20 and the forward PE ratio is 13.04.
| PE Ratio | 15.20 |
| Forward PE | 13.04 |
| PS Ratio | 1.77 |
| PB Ratio | 1.58 |
| P/TBV Ratio | 1.84 |
| P/FCF Ratio | 10.54 |
| P/OCF Ratio | 8.32 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.06, with an EV/FCF ratio of 9.66.
| EV / Earnings | 13.85 |
| EV / Sales | 1.62 |
| EV / EBITDA | 6.06 |
| EV / EBIT | 7.74 |
| EV / FCF | 9.66 |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.80 |
| Quick Ratio | 1.43 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.13 |
| Interest Coverage | 499.82 |
Financial Efficiency
Return on equity (ROE) is 16.19% and return on invested capital (ROIC) is 11.46%.
| Return on Equity (ROE) | 16.19% |
| Return on Assets (ROA) | 9.35% |
| Return on Invested Capital (ROIC) | 11.46% |
| Return on Capital Employed (ROCE) | 18.15% |
| Revenue Per Employee | 20.77M |
| Profits Per Employee | 2.44M |
| Employee Count | 501 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 2.80 |
Taxes
In the past 12 months, Grape King Bio has paid 440.37 million in taxes.
| Income Tax | 440.37M |
| Effective Tax Rate | 19.01% |
Stock Price Statistics
The stock price has decreased by -16.22% in the last 52 weeks. The beta is 0.43, so Grape King Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -16.22% |
| 50-Day Moving Average | 127.00 |
| 200-Day Moving Average | 129.63 |
| Relative Strength Index (RSI) | 33.49 |
| Average Volume (20 Days) | 79,014 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Grape King Bio had revenue of TWD 10.40 billion and earned 1.22 billion in profits. Earnings per share was 8.19.
| Revenue | 10.40B |
| Gross Profit | 7.87B |
| Operating Income | 2.16B |
| Pretax Income | 2.32B |
| Net Income | 1.22B |
| EBITDA | 2.70B |
| EBIT | 2.16B |
| Earnings Per Share (EPS) | 8.19 |
Balance Sheet
The company has 3.26 billion in cash and 231.69 million in debt, with a net cash position of 3.03 billion or 20.46 per share.
| Cash & Cash Equivalents | 3.26B |
| Total Debt | 231.69M |
| Net Cash | 3.03B |
| Net Cash Per Share | 20.46 |
| Equity (Book Value) | 11.64B |
| Book Value Per Share | 68.53 |
| Working Capital | 2.07B |
Cash Flow
In the last 12 months, operating cash flow was 2.22 billion and capital expenditures -468.69 million, giving a free cash flow of 1.75 billion.
| Operating Cash Flow | 2.22B |
| Capital Expenditures | -468.69M |
| Free Cash Flow | 1.75B |
| FCF Per Share | 11.81 |
Margins
Gross margin is 75.66%, with operating and profit margins of 20.77% and 11.73%.
| Gross Margin | 75.66% |
| Operating Margin | 20.77% |
| Pretax Margin | 22.26% |
| Profit Margin | 11.73% |
| EBITDA Margin | 25.91% |
| EBIT Margin | 20.77% |
| FCF Margin | 16.81% |
Dividends & Yields
This stock pays an annual dividend of 6.40, which amounts to a dividend yield of 5.16%.
| Dividend Per Share | 6.40 |
| Dividend Yield | 5.16% |
| Dividend Growth (YoY) | -33.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 83.77% |
| Buyback Yield | 0.06% |
| Shareholder Yield | 5.22% |
| Earnings Yield | 6.62% |
| FCF Yield | 9.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 15, 2005. It was a forward split with a ratio of 1.0205.
| Last Split Date | Sep 15, 2005 |
| Split Type | Forward |
| Split Ratio | 1.0205 |
Scores
Grape King Bio has an Altman Z-Score of 6.31 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.31 |
| Piotroski F-Score | 5 |